Who are Nyxoah SA's main suppliers?

Nyxoah SA (NYXH) key suppliers include: SINGLE-SOURCE-SUPPLIER, Inspire Medical Systems, Inc.. View the full supplier network at chainsifter.com/chain/NYXH.

Who are Nyxoah SA's major customers?

Nyxoah SA (NYXH) key customers include: Inspire Medical Systems, Inc., Inspire Medical Systems, Inc., LivaNova PLC, LivaNova PLC, COCHLEAR-INVESTMENTS-PTY-LTD and 13 more. View the full customer network at chainsifter.com/chain/NYXH.

What sector is Nyxoah SA in?

Nyxoah SA (NYXH) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Nyxoah SA (NYXH) Supply Chain: 21 Verified Relationships

2Suppliers

18Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Nyxoah SA (NYXH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

22Total relationships

1Distinct source URLs

3High confidence

0.681Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Nyxoah SA Suppliers

Ticker	Name	Confidence	Evidence
SINGLE-SOURCE-SUPPLIER	SINGLE-SOURCE-SUPPLIER	90%	For instance, we currently rely on a single source supplier for a number of critical components to the Genio system.
INSP	Inspire Medical Systems, Inc.	72%	Reciprocal relationship from INSP graph: coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs provide coverage of Inspire therapy when …

Nyxoah SA Customers

Ticker	Name	Confidence	Evidence
INSP	Inspire Medical Systems, Inc.	72%	risks to our business could intensify. Changes in laws or regulations associated with the enhanced protection of certain types of sensitive data, for the treatment of genetic data, along with increas…
INSP	Inspire Medical Systems, Inc.	72%	Reciprocal relationship from INSP graph: coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs provide coverage of Inspire therapy when …
LIVN	LivaNova PLC	72%	Reciprocal relationship from LIVN graph: Reciprocal relationship from NYXH graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from NYXH graph: Reciprocal relationship from LIVN g…
LIVN	LivaNova PLC	72%	obtain marketing authorization or certification for a product in a particular country but then be subject to price regulations that delay commercial launch of the product, possibly for lengthy time p…
COCHLEAR-INVESTMENTS-PTY-LTD	COCHLEAR-INVESTMENTS-PTY-LTD	62%	4 2023 By Function: Sales, General & Administration 81.2 56.5 40.4 Research & Development 72.5 127.1 106.4 Total 153.7 183.6 146.8 By Geography: Europe (Belgium & Germ…
COCHLEAR-LIMITED	COCHLEAR-LIMITED	62%	4 2023 By Function: Sales, General & Administration 81.2 56.5 40.4 Research & Development 72.5 127.1 106.4 Total 153.7 183.6 146.8 By Geography: Europe (Belgium & Germ…
EMERGING-GROWTH-COMPANY	EMERGING-GROWTH-COMPANY	62%	e further integrated controlling processes within our ERP system, updated the design of controls to reflect changes in our organizational structure and ERP environment, and maintained and further con…
IMTHERA-LIVANOVA-PLC	IMTHERA-LIVANOVA-PLC	62%	obtain marketing authorization or certification for a product in a particular country but then be subject to price regulations that delay commercial launch of the product, possibly for lengthy time p…
INSPIRE-MEDICAL-INC	INSPIRE-MEDICAL-INC	62%	onsideration of the first tranche for € 22.5 million. The difference between the transaction price and the fair value at initial recognition is considered a ‘day 1’ loss, amounting to € 8.7 million, …
INSPIRE-MEDICAL-SYSTEMS-EUROPE-GMBH	INSPIRE-MEDICAL-SYSTEMS-EUROPE-GMBH	62%	risks to our business could intensify. Changes in laws or regulations associated with the enhanced protection of certain types of sensitive data, for the treatment of genetic data, along with increas…
JH-CAPITAL-GMBH	JH-CAPITAL-GMBH	62%	4 2023 By Function: Sales, General & Administration 81.2 56.5 40.4 Research & Development 72.5 127.1 106.4 Total 153.7 183.6 146.8 By Geography: Europe (Belgium & Germ…
MFF-OWN-RESOURCES	MFF-OWN-RESOURCES	62%	m or abroad), are also subject to the annual tax. The financial instruments envisaged include not only shares, bonds and notes, but also derivatives. Each securities account would be assessed separat…
NVNO	enVVeno Medical Corporation	62%	Reciprocal relationship from NVNO graph: Reciprocal relationship from NYXH graph: Reciprocal relationship from NVNO graph: Reciprocal relationship from NYXH graph: obtain marketing authorization or c…
NYXOAH-GMBH	NYXOAH-GMBH	62%	ies based on the relative estimated standalone selling price, with revenue deferred and recognized at a point in time upon transfer of control at shipment or delivery, depending on contractual terms.…
NYXOAH-PTY-LTD	NYXOAH-PTY-LTD	62%	ies based on the relative estimated standalone selling price, with revenue deferred and recognized at a point in time upon transfer of control at shipment or delivery, depending on contractual terms.…
SI	Shoulder Innovations, Inc.	62%	Reciprocal relationship from SI graph: Reciprocal relationship from NYXH graph: ers. 7 Table of Contents In addition, any future debt financing into which we enter may impose upon us covenants that r…
SILVERGATE-CAPITAL-CORP	SILVERGATE-CAPITAL-CORP	62%	ers. 7 Table of Contents In addition, any future debt financing into which we enter may impose upon us covenants that restrict our operations, including limitations on our ability to incur liens or a…
WILDMAN-VENTURES-LLC	WILDMAN-VENTURES-LLC	62%	4 2023 By Function: Sales, General & Administration 81.2 56.5 40.4 Research & Development 72.5 127.1 106.4 Total 153.7 183.6 146.8 By Geography: Europe (Belgium & Germ…

Nyxoah SA Debt Obligations

Instrument	Description	Confidence	Evidence
NYXH-DEBT	Debt stack $42.1M	90%	Market cache reports total debt of $42.1M.

Nyxoah SA Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Nyxoah SA.

Nyxoah SA Ownership

Holder	Name	Confidence	Evidence
NYXH-OWNER-VESTAL-POINT-CAPITAL-LP	Vestal Point Capital, LP	90%	13F overlay lists Vestal Point Capital, LP as top holder; 34 tracked holders.

Nyxoah SA Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SI	Shoulder Innovations, Inc.	100.00	1	['customer']
NPCE	NeuroPace, Inc.	100.00	2
NVNO	enVVeno Medical Corporation	100.00	1	['customer']
CAN	Canaan Inc.	50.00	2
GEMI	Gemini Space Station, Inc.	50.00	2
IRON	Disc Medicine, Inc.	50.00	2
ALLO	Allogene Therapeutics, Inc.	50.00	2
TAOP	Taoping Inc.	50.00	2
ACET	Adicet Bio, Inc.	50.00	2
BTM	Bitcoin Depot Inc.	50.00	2
ITUB	Itaú Unibanco Holding S.A.	50.00	2
ICG	Intchains Group Limited	50.00	2
TRIN	Trinity Capital Inc.	50.00	2
TVTX	Travere Therapeutics, Inc.	50.00	2
NRIX	Nurix Therapeutics, Inc.	50.00	2
MDT	Medtronic plc	50.00	2
RLX	RLX Technology Inc.	50.00	2
XTKG	X3 Holdings Co Ltd	50.00	2
IFNNF	Infineon Technologies AG	50.00	2
JNJ	Johnson & Johnson	50.00	2

Nyxoah SA Supply Chain